Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study

Abstract

Ketamine appears to be a relatively effective and safe drug for the treatment of RSE. This retrospective series provides preliminary data on effective dose and appropriate time of intervention to aid in the design of a prospective trial to further define the role of ketamine in the treatment of RSE.